Vertex Pharmaceuticals Inc. (VRTX) Social Stream
VERTEX PHARMACEUTICALS INC (VRTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VRTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 19 | $331 | $175 | $262.5 | $421.01 | -37.65% |
| 2021-11-19 | 20 | $331 | $175 | $255 | $421.01 | -39.43% |
| 2021-11-28 | 19 | $331 | $175 | $252 | $421.01 | -40.14% |
| 2021-12-02 | 19 | $341 | $175 | $252.526 | $421.01 | -40.02% |
| 2021-12-05 | 19 | $341 | $175 | $253.315 | $421.01 | -39.83% |
| 2021-12-09 | 20 | $341 | $175 | $254.15 | $421.01 | -39.63% |
| 2022-01-07 | 20 | $341 | $175 | $255.65 | $421.01 | -39.28% |
| 2022-01-10 | 19 | $341 | $201 | $259.894 | $421.01 | -38.27% |
| 2022-01-26 | 19 | $341 | $203 | $264.578 | $421.01 | -37.16% |
| 2022-01-28 | 19 | $341 | $208 | $268 | $421.01 | -36.34% |
| 2022-02-03 | 19 | $341 | $208 | $268.21 | $421.01 | -36.29% |
| 2022-03-14 | 18 | $341 | $208 | $268.21 | $421.01 | -36.29% |
| 2022-03-22 | 18 | $341 | $208 | $268.421 | $421.01 | -36.24% |
| 2022-03-31 | 17 | $341 | $208 | $267.722 | $421.01 | -36.41% |
| 2022-04-04 | 17 | $350 | $208 | $270.222 | $421.01 | -35.82% |
| 2022-04-05 | 17 | $350 | $208 | $271.888 | $421.01 | -35.42% |
| 2022-04-13 | 16 | $350 | $210 | $275.421 | $421.01 | -34.58% |
| 2022-04-17 | 16 | $350 | $210 | $278.578 | $421.01 | -33.83% |
| 2022-05-04 | 16 | $350 | $210 | $280.631 | $421.01 | -33.34% |
| 2022-05-06 | 18 | $350 | $210 | $282.105 | $421.01 | -32.99% |
| 2022-05-09 | 19 | $350 | $210 | $283.736 | $421.01 | -32.61% |
| 2022-05-22 | 19 | $350 | $210 | $282.479 | $421.01 | -32.9% |
| 2022-05-23 | 19 | $350 | $210 | $282.8 | $421.01 | -32.83% |
| 2022-06-03 | 19 | $350 | $210 | $284.809 | $421.01 | -32.35% |
| 2022-06-13 | 18 | $350 | $240 | $289.222 | $421.01 | -31.3% |
| 2022-07-26 | 19 | $365 | $240 | $296.764 | $421.01 | -29.51% |
| 2022-08-03 | 19 | $365 | $240 | $298 | $421.01 | -29.22% |
| 2022-08-05 | 20 | $365 | $240 | $298 | $421.01 | -29.22% |
| 2022-08-08 | 20 | $365 | $250 | $301.526 | $421.01 | -28.38% |
| 2022-08-14 | 20 | $365 | $250 | $301.684 | $421.01 | -28.34% |
| 2022-09-27 | 20 | $365 | $250 | $303.368 | $421.01 | -27.94% |
| 2022-10-12 | 20 | $365 | $250 | $303.631 | $421.01 | -27.88% |
| 2022-10-16 | 20 | $365 | $250 | $303.894 | $421.01 | -27.82% |
| 2022-10-21 | 20 | $365 | $250 | $304.157 | $421.01 | -27.76% |
| 2022-10-28 | 20 | $365 | $250 | $304.578 | $421.01 | -27.66% |
| 2022-10-31 | 20 | $365 | $250 | $307 | $421.01 | -27.08% |
| 2022-11-11 | 20 | $365 | $250 | $311.578 | $421.01 | -25.99% |
| 2022-12-08 | 20 | $365 | $250 | $312.631 | $421.01 | -25.74% |
| 2023-01-09 | 20 | $365 | $250 | $312.631 | $421.01 | -25.74% |
| 2023-01-17 | 20 | $374 | $250 | $318.368 | $421.01 | -24.38% |
| 2023-01-18 | 20 | $374 | $250 | $321 | $421.01 | -23.75% |
| 2023-01-23 | 19 | $374 | $250 | $321 | $421.01 | -23.75% |
| 2023-01-27 | 19 | $374 | $250 | $321.055 | $421.01 | -23.74% |
| 2023-02-07 | 18 | $374 | $250 | $321.055 | $421.01 | -23.74% |
| 2023-02-08 | 18 | $374 | $250 | $319.944 | $421.01 | -24.01% |
| 2023-02-09 | 18 | $365 | $250 | $322.222 | $421.01 | -23.46% |
| 2023-02-13 | 17 | $365 | $250 | $326.117 | $421.01 | -22.54% |
| 2023-03-29 | 18 | $365 | $250 | $327.111 | $421.01 | -22.3% |
| 2023-05-01 | 18 | $365 | $250 | $327.235 | $421.01 | -22.27% |
| 2023-05-03 | 20 | $456 | $288 | $360.941 | $421.01 | -14.27% |
| 2023-05-04 | 22 | $456 | $305 | $365.631 | $421.01 | -13.15% |
| 2023-06-06 | 22 | $456 | $305 | $366.45 | $421.01 | -12.96% |
| 2023-06-14 | 22 | $456 | $305 | $366.85 | $421.01 | -12.86% |
| 2023-06-22 | 21 | $456 | $305 | $368.105 | $421.01 | -12.57% |
| 2023-06-26 | 22 | $456 | $305 | $368.65 | $421.01 | -12.44% |
| 2023-06-29 | 22 | $456 | $305 | $369.15 | $421.01 | -12.32% |
| 2023-06-30 | 22 | $456 | $323 | $370.9 | $421.01 | -11.9% |
| 2023-07-20 | 22 | $456 | $323 | $373.2 | $421.01 | -11.36% |
| 2023-07-24 | 22 | $456 | $323 | $375.7 | $421.01 | -10.76% |
| 2023-08-02 | 23 | $456 | $323 | $375.7 | $421.01 | -10.76% |
| 2023-08-03 | 24 | $456 | $325 | $385.095 | $421.01 | -8.53% |
| 2023-08-07 | 24 | $456 | $315 | $381.909 | $421.01 | -9.29% |
| 2023-09-29 | 24 | $456 | $315 | $382.136 | $421.01 | -9.23% |
| 2023-10-09 | 24 | $456 | $315 | $382.454 | $421.01 | -9.16% |
| 2023-10-25 | 25 | $456 | $315 | $383.59 | $421.01 | -8.89% |
| 2023-11-06 | 25 | $456 | $315 | $382.782 | $421.01 | -9.08% |
| 2023-11-08 | 25 | $456 | $315 | $391.347 | $421.01 | -7.05% |
| 2023-11-10 | 25 | $456 | $315 | $392.652 | $421.01 | -6.74% |
| 2023-12-13 | 26 | $456 | $315 | $392 | $421.01 | -6.89% |
| 2023-12-14 | 26 | $485 | $315 | $393.791 | $421.01 | -6.47% |
| 2023-12-22 | 26 | $485 | $315 | $395.75 | $421.01 | -6% |
The Trend in the Analyst Price Target
VRTX's average price target has moved up $135.02 over the prior 30 months.
VRTX reports an average of 4.39% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 18 | 374 | 250 | 319.944 | 293.33 | 9.07% |
| 2023-03-29 | 18 | 365 | 250 | 327.111 | 314.24 | 4.1% |
| 2023-04-16 | 18 | 365 | 250 | 327.235 | 333.52 | -1.88% |
| 2023-11-06 | 25 | 456 | 315 | 382.782 | 385.76 | -0.77% |
| 2023-12-14 | 26 | 485 | 315 | 395.125 | 406.60 | -2.82% |
VRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 18 | 0 | 8 | 0 | 0 | 26 |
The Trend in the Broker Recommendations
Over the past 46 months, VRTX's average broker recommendation rating worsened by 0.16.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, VERTEX PHARMACEUTICALS INC's average analyst price target is higher than 8562.51% of them.
- VERTEX PHARMACEUTICALS INC's number of analysts covering the stock is greater than 8597.49% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, VERTEX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 543.19% of them.
- VRTX has a lower variance in analysts' estimates than -2335.73% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VERTEX PHARMACEUTICALS INC are RPRX, RGNX, and HALO.
View All Top Stocks by Price Target
Make investment decisions regarding VRTX using the data that counts. Try POWR Ratings for free.